A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body, according to a new study from researchers at Weill Cornell Medicine.
Novel Technique Provides Insights into Lung Pathology in COVID-19
March 11, 2022
Investigators at Weill Cornell Medicine and NewYork-Presbyterian have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases. In the study, published in the May 2021 issue of Nature, the researchers imaged autopsied lung tissue in a way that simultaneously highlighted dozens of molecular markers on cells.
EIPM Researcher Wins Starr Cancer Consortium Funding
March 10, 2022
Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium. Both grants will fund work applying new technologies to develop more detailed knowledge of tumor biology, with one team focusing on Hodgkin lymphoma and the other on the purity of tumor samples on pathology slides.
The Next Life-Saving Innovation Developed Only for You
March 7, 2022
When most people think of making technology more personalized, they imagine chatbots, or artificial intelligence programmed to speak in a human voice that turns search-engine output into small talk.
At Weill Cornell Medicine in New York City, personalized technology can mean the ability to map a patient’s entire genetic code in the time it takes to watch a movie, or tracking flecks of DNA in the blood to assess if a disease treatment is working.
EIPM’s Dr. Bishoy M. Faltas Wins 2022 Science Award ASCI Young Physician-Scientist Awards
March 3, 2022
Three Weill Cornell Medicine faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation. The 2022 award recipients are Drs. Bishoy M. Faltas, Gunisha Kaur and Hasina Outtz Reed.
March 2022 EIPM Director's Memo
March 3, 2022
Dear Members of the Englander Institute,
February was a busy month for many of our colleagues who participated in live and virtual events (see below). By sharing their expertise across a wide range of topics, these events help attract attention to the EIPM and raise our profile as we continue to grow and recruit new talent. Thank you for taking the time out of your busy schedules to participate in these panels and conferences.
February 2022 EIPM Director's Memo
February 1, 2022
Dear Members of the Englander Institute,
I hope this message finds you doing well and staying healthy! It’s hard to believe that January is already behind us, but as you’ll see below, we have a lot to show for the first month of 2022.
In addition to robust news coverage, awards, events, and publications, we welcome three new senior members of our team. Drs. Cristofanilli, Kasi, and Al Assaad bring a wealth of experience and talent to the EIPM.
A Conversation with Majd Al Assaad, M.D.
January 20, 2022
We are pleased to introduce you to our new colleague Majd Al Assaad, M.D., a Research Fellow in Precision Medicine in the Department of Pathology and Laboratory Medicine, and a Member of the Englander Institute for Precision Medicine.
Dr. Assaad worked as an Oncology Postdoctoral Research Fellow at the American University of Beirut Medical Center before completing one year of pathology residency at the same institution, and has research experience in basic science and organic & inorganic chemistry.
Winter 2021 EIPM Newsletter
January 10, 2022
December 31, 2021
Dear Friend of the Englander Institute for Precision Medicine,
EIPM Researcher Awarded Grant to Study Type 1 Diabetes
January 5, 2022
Researchers Awarded Grant to Study New Method of Islet Transplantation
Weill Cornell Medicine researchers have received a two-year $500,000 grant from JDRF to evaluate an innovative approach to islet cell transplantation, an experimental treatment for difficult-to-control type 1 diabetes. The research will be conducted in mouse models of this disease.